Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Beigene, ltd. crawled date : 2021 - 05 - 05 save search
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-05 (Crawled : 18:31) - fda.gov
PFE A | $25.91 0.19% -0.04% 34M
|
Health Technology
|
| O: -3.73%
H: 1.95%
C: 1.85%
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
|
| O: -0.65%
H: 1.33%
C: 1.22%
BMY | $48.51 0.48% 0.0% 12M
|
Health Technology
|
| O: -0.12%
H: 0.19%
C: -0.22%
ADCT | $4.37 -0.46% 0.0% 460K
|
Health Technology
|
| O: 3.45%
H: 1.01%
C: -0.66%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.67%
H: 1.03%
C: 0.94%
YMAB | $14.91 3.76% 3.62% 300K
|
Health Technology
|
| O: -0.85%
H: 2.64%
C: 2.1%
VSTM | $11.07 -2.04% -2.08% 120K
|
Health Technology
|
| O: -2.03%
H: 0.82%
C: -1.72%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.55%
H: 0.51%
C: 0.29%
RIGL | $1.16 -3.33% -3.45% 770K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -6.05%
REGN | $898.33 -0.7% -0.71% 650K
|
Health Technology
|
| O: 0.14%
H: 4.11%
C: 3.22%
KPTI | $1.155 -5.33% -5.63% 810K
|
Health Technology
|
| O: 0.37%
H: 1.11%
C: 0.0%
INCY | $53.42 -0.8% -0.8% 1.6M
|
Health Technology
|
| O: -0.09%
H: 1.99%
C: 1.35%
ILMN | $121.18 -4.64% -4.86% 1.6M
|
Health Technology
|
| O: -0.64%
H: 0.34%
C: 0.31%
EXEL 4 | $22.695 0.2% 0.2% 1.8M
|
Health Technology
|
| O: -0.88%
H: 0.34%
C: -2.27%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: -9.2%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: -0.34%
H: 0.86%
C: -2.91%
BPMC | $85.19 -2.36% -2.42% 510K
|
Health Technology
|
| O: -0.26%
H: 2.88%
C: 2.72%
BGNE S | $138.39 -2.06% -2.1% 230K
|
Health Technology
|
| O: 0.14%
H: 3.67%
C: 2.67%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.3%
H: 0.15%
C: -1.78%
AMGN | $265.505 -0.66% -0.67% 1.7M
|
Health Technology
|
| O: -0.03%
H: 0.88%
C: 0.81%
ALNY | $147.775 -0.49% -0.49% 490K
|
Health Technology
|
| O: -0.51%
H: 1.52%
C: 0.08%
AGIO | $29.29 -0.75% -0.75% 620K
|
Health Technology
|
| O: -0.45%
H: 4.45%
C: 3.9%
cancer approval
FDA Accepts Amgen's Supplemental New Drug Application For Otezla® (apremilast) For Adults With Mild-To-Moderate Plaque Psoriasis
Published: 2021-05-05 (Crawled : 14:15) - biospace.com/
BGNE S | $138.39 -2.06% -2.1% 230K
|
Health Technology
|
| O: -0.5%
H: 3.2%
C: -1.07%
AMGN | $265.505 -0.66% -0.67% 1.7M
|
Health Technology
|
| O: -0.43%
H: 1.5%
C: 1.24%
new drug fda drug psoriasis fda acceptance application plague
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.